UMIN ID: UMIN000045714
Registered date:11/10/2021
Utility of DWI-MRI and histopathological evaluation on early response of HCC with molecular targeting therapy
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Hepatocellular carcinoma |
Date of first enrollment | 2020/10/11 |
Target sample size | 50 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Relationship between DWI-MRI, histopathologic evaluation, and exosome and radiological response on RECIST 1.1 |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1. Allergy with iodine contrast media 2. eGFR is less than 40ml/min 3. Child-Pugh is B and C 4. Not suitable for the study due to researcher's decision |
Related Information
Primary Sponsor | Tokyo Medical University |
---|---|
Secondary Sponsor | Dept. of pathology, Keio University |
Source(s) of Monetary Support | Tokyo Medical University |
Secondary ID(s) |
Contact
public contact | |
Name | Katsutoshi Sugimoto |
Address | 6-7-1, NIshi-shinjuku, Shinjuku-ku, Tokyo Japan 160-0023 |
Telephone | 03-3342-6111 |
sugimoto@tokyo-med.ac.jp | |
Affiliation | Tokyo Medical University Dept. of Gastroenterology and Hepatology |
scientific contact | |
Name | Katsutoshi Sugimoto |
Address | 6-7-1, NIshi-shinjuku, Shinjuku-ku, Tokyo Japan |
Telephone | 03-3342-6111 |
sugimoto@tokyo-med.ac.jp | |
Affiliation | Tokyo Medical University Dept. of Gastroenterology and Hepatology |